Covariate | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | ||
Recurrence-free survival | |||||||
cT | 2.46 | 1.39–4.33 | 0.0033 | 1.43 | 0.70–2.89 | 0.3620 | |
cN | 2.89 | 1.49–5.60 | 0.0016 | 2.25 | 1.03–4.92 | 0.0423 | |
ypT | 2.14 | 1.33–3.43 | 0.0025 | 1.68 | 0.91–3.09 | 0.0940 | |
ypN | 1.95 | 1.20–3.18 | 0.0171 | 0.77 | 0.37–1.59 | 0.4880 | |
BRCA | 0.79 | 0.25–2.49 | 0.6952 | ||||
pCR | 0.34 | 0.07–1.45 | 0.0971 | ||||
Platinum-based NAC | 1.15 | 0.41–3.24 | 0.7852 | ||||
Ki67 group | 0.51 | 0.17–1.48 | 0.2056 | ||||
Age group | 1.49 | 0.71–3.13 | 0.2803 | ||||
Overall survival | |||||||
cT | 2.20 | 1.09–4.44 | 0.0274 | 0.73 | 0.25–2.14 | 0.5698 | |
cN | 2.02 | 1.17–3.48 | 0.0123 | 3.42 | 1.00–11.62 | 0.0502 | |
ypT | 1.86 | 1.05–3.32 | 0.0349 | 1.27 | 0.53–3.05 | 0.5919 | |
ypN | 2.16 | 1.21–3.84 | 0.0091 | 0.90 | 0.40–2.81 | 0.4996 | |
BRCA | 0.77 | 0.16–3.72 | 0.7487 | ||||
pCR | 0.36 | 0.04–2.94 | 0.3484 | ||||
Platinum-based NAC | 7.02 | 0.88–55.62 | 0.0213 | 7.52 | 0.75–70.04 | 0.0885 | |
Ki67 group | 0.58 | 0.14–2.30 | 0.4283 | ||||
Age group | 1.20 | 0.47–3.08 | 0.6995 |